You are here

Prices & Quotes - UK Markets - Polarean Imaging (POLX)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Down 56.00p
Change Today:
-1.00p
Market Cap:
117.18m
Sector:
Health Care Equipment & Services

Polarean Imaging new drug application gets FDA acceptance

By Josh White

Date: Wednesday 23 Dec 2020

LONDON (ShareCast) - (Sharecast News) - Medical imaging technology company Polarean Imaging updated the market on the status of its new drug application with the US Food and Drug Administration (FDA) on Wednesday.
The AIM-traded firm said it had received notification of acceptance of the application by the FDA.

It said the FDA had confirmed that the review would follow the standard review time frame, with a target Prescription Drug User Fee Act (PDUFA) action date of 5 October 2021.

The company said it was planning to make full use of that time for commercialisation and launch preparation.

"FDA acceptance for the filing of Polarean's NDA represents another important step forward for the company's platform," said chief executive officer Richard Hullihen.

"If approved, Polarean's drug-device technology could provide a new diagnostic option for patients with pulmonary disease."

Polarean also announced the planned retirement of its chief operating officer Ken West as an employee.

The board said it had approved West's continued involvement with Polarean as a consultant to the company, with West to transition to being a non-executive director with immediate effect.

"The board would like to thank Ken for his expert and untiring contributions, particularly in managing the NDA submission and its successful acceptance by FDA for review," Richard Hullihen added.

At 1135 GMT, shares in Polarean Imaging were down 6.71% at 69.97p.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

POLX Market Data

Currency UK Pounds
Price 56.00p
Change Today -1.00p
52 Week High 106.50p
52 Week Low 42.80p
Volume 553,585
Shares Issued 209.25m
Market Cap 117.18m
Beta 0.02

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Price Trend
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. empty sector
  4. empty sector
  5. empty sector
Income
Not Available
Growth
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Price Chg 6m
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
P/E
Not Available
PEG
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. empty sector
  5. empty sector
Dividend Yield
Not Available
EPS Growth
Not Available
Operating Margin
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. half sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector

POLX Dividends

No dividends found

Trades for 21-Jan-2022

Time Volume / Share Price
17:05 98,500 @ 56.00p
15:35 50,000 @ 56.20p
16:35 1,700 @ 56.00p
16:24 16,201 @ 54.55p
16:14 10,000 @ 54.55p

POLX Key Personnel

CEO Richard Hullihen
CFO Charles Osborne